$PAWS Today executed a very good acquisition of a pharmaceutical company, Mesa, doing $3.4M a month in revenue. The stock is trading at 2.6 cents and the valuation of this merger is likely $2.00-$3.00 in PPS in terms of net income, OS and PE ratio of 20. Everyone reading this message should come visit our PAWS board here on IH, mark the board and learn more about this hidden OTCQB SEC reporting jewel !